Roth Capital Downgrades Alnylam Pharmaceuticals (ALNY) to Hold. Price Target Cut
Tweet Send to a Friend
Roth Capital downgrades Alnylam Pharmaceuticals (Nasdaq: ALNY) to Hold ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE